Technology Transfer in Pharma: The Validation Checklist Nobody Gives You

What actually needs to be validated during a technology transfer

The short answer: almost everything at the receiving site. The longer answer involves understanding what can be leveraged from the sending site and what must be done fresh.

• Equipment qualification. Equipment at the receiving site needs IQ/OQ/PQ regardless of what was done at the sending site. Even if the equipment is identical make and model, the installation is different, the utilities are different, and the environmental conditions may be different.
• Process validation. The process needs to be validated at the receiving site. You can leverage the Stage 1 process understanding from the sending site, but Stage 2 Process Performance Qualification must be performed at the receiving site with its specific equipment, operators, and conditions.
• Cleaning validation. Cleaning procedures may need to be modified for different equipment configurations at the receiving site, and cleaning validation must be performed with the receiving site's equipment.
• Analytical method transfer. Analytical methods used for in-process testing, release testing, and stability testing must be transferred and verified at the receiving site's laboratory.
• Computerised system validation. If the receiving site uses different computerised systems (different LIMS, different MES, different ERP), those systems need to be validated for the transferred process. Even if the systems are the same platform, the configuration may be different.
• Utility qualification. Water systems, HVAC, compressed gases, and other utilities at the receiving site need to be qualified for the transferred process.

The validation gap analysis: your most important tool

Before you start any validation work at the receiving site, conduct a thorough gap analysis that compares the validated state at the sending site with the current state at the receiving site. For each system, process, and method, document what exists at the sending site (validated equipment, processes, methods, systems), what exists at the receiving site (existing qualifications, available equipment, systems in place), and the gap between them (what new validation is needed, what can be leveraged, what must be done from scratch). This gap analysis drives your transfer validation plan and prevents two common problems: doing unnecessary validation work (re-validating things that are already validated at the receiving site) and missing necessary validation work (assuming something is covered when it is not). GxP Copilot can generate the gap analysis framework and track completion of each validation activity across the transfer timeline.

Analytical method transfer: the piece that takes longest

In our experience, analytical method transfer is consistently the activity that takes longer than planned and causes the most delays in the overall technology transfer timeline. The sending laboratory has years of experience with the methods. Their analysts know the tricks — the precise way to prepare a sample, the environmental conditions that affect the assay, the system suitability criteria that indicate when something is off. Transferring that tacit knowledge along with the formal method documentation is difficult. A formal analytical method transfer protocol typically includes equivalency testing (the receiving lab runs the same samples as the sending lab and demonstrates statistically equivalent results), robustness testing (the receiving lab demonstrates the method works within its specified parameters), and training verification (the receiving lab's analysts demonstrate competency with the method). Do not underestimate this. Build at least 50% more time into your transfer plan for analytical method transfer then your initial estimate.

Regulatory considerations for technology transfers

Technology transfers often have regulatory implications that must be addressed before the transfer is complete. A manufacturing site change for a marketed product requires regulatory notification or approval in most jurisdictions — the specific requirement depends on the product type, the regulatory authority, and the nature of the change. In the US, a manufacturing site change may require a Prior Approval Supplement (PAS) to the NDA or ANDA, which means FDA must approve the change before you can distribute product from the new site. In the EU, a manufacturing site change is typically a Type II Variation that requires assessment by the national competent authority. The validation evidence from the receiving site is a critical component of these regulatory submissions. Your validation documentation needs to be regulatory-submission-ready, not just internally adequate.

What we see going wrong in technology transfer validation

• Starting validation too late. Validation should begin early in the transfer process, not after the equipment is installed and the process is transferred. Start with the gap analysis while the transfer plan is still being developed.
• Underestimating the timeline. Every technology transfer takes longer than planned. Build contingency into your validation timeline — at least 30% buffer for the activities you think are straightforward and 50% for analytical method transfer.
• Poor knowledge transfer. The sending site's tacit knowledge is as important as the formal documentation. Plan for extended on-site training where sending site personnel work alongside receiving site personnel during qualification activities.
• Not aligning quality systems. If the sending and receiving sites use different quality systems, SOPs, and documentation practices, you need to align these before validation begins — otherwise your validation documentation will be inconsistent and hard to review.